Description

HYDROZOLIN ISDN is a clinically trusted combination therapy containing Isosorbide Dinitrate (20 mg) and Hydralazine (37.5 mg), two well-established medicines used in cardiovascular care. This combination is primarily prescribed for the management of heart failure and hypertension, especially in patients who need an effective treatment option that enhances blood flow, reduces workload on the heart, and improves overall cardiac function. By combining a nitrate and a vasodilator, HYDROZOLIN ISDN helps patients achieve better control over symptoms such as shortness of breath, chest discomfort, and fatigue, offering improved quality of life. Uses HYDROZOLIN ISDN is recommended for the following conditions: 1. Heart Failure Management Helps reduce the strain on the heart by dilating blood vessels and improving cardiac efficiency. 2. Hypertension (High Blood Pressure) Lowers blood pressure by relaxing vascular smooth muscles, easing the movement of blood through the arteries. 3. Angina (Chest Pain) Isosorbide Dinitrate reduces the frequency and intensity of angina episodes by improving oxygen supply to the heart. 4. Afterload and Preload Reduction Plays an important role in decreasing the heart’s workload, making it beneficial for patients with compromised heart function. Benefits 1. Dual Mechanism for Stronger Relief Isosorbide Dinitrate acts as a nitrate that dilates veins, while Hydralazine dilates arteries. This dual action enhances blood flow and reduces pressure on the heart. 2. Improved Exercise Tolerance Patients using HYDROZOLIN ISDN often experience better stamina and reduced breathlessness during physical activities. 3. Reduced Hospitalizations in Heart Failure Studies support the effectiveness of nitrate-hydralazine combinations in improving heart function and reducing exacerbations of chronic heart failure. 4. Enhanced Blood Pressure Control Hydralazine ensures sustained arterial relaxation, contributing to better long-term blood pressure management. 5. Symptom Relief for Chronic Angina By improving coronary blood supply, Isosorbide Dinitrate helps decrease chest pain episodes and enhances comfort. 6. Suitable for Patients Needing an Alternative Therapy Useful when patients are unable to tolerate ACE inhibitors or other first-line heart failure medicines. Dosage The dosage of HYDROZOLIN ISDN should always be individualized based on the patient’s condition and medical guidance. General recommendations include: Adults: Typically 1 tablet taken 2–3 times daily, as directed by the physician. Tablets should be swallowed whole with water. Do not abruptly stop the medication without consulting a doctor. Maintain consistent timing each day for best results. Patients with kidney disease, liver issues, or low blood pressure require special medical supervision. Side Effects HYDROZOLIN ISDN is generally well tolerated, but some individuals may experience: Headache Dizziness or light-headedness Flushing Fast or irregular heartbeat Low blood pressure Nausea Fatigue Rare but serious effects include swelling, breathing difficulty, or severe drop in blood pressure. Immediate medical attention is needed if these occur. Conclusion HYDROZOLIN ISDN combines the benefits of Isosorbide Dinitrate and Hydralazine to provide an effective treatment option for heart failure, hypertension, and angina. Its dual vasodilatory action enhances blood flow, lowers cardiac workload, and eases symptoms that interfere with daily life. When used under proper medical supervision, HYDROZOLIN ISDN supports better heart health, improved functional capacity, and long-term cardiovascular stability.